BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34768927)

  • 21. Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic inflammation after haemorrhagic shock.
    Yin L; Busch D; Qiao Z; van Griensven M; Teuben M; Hildebrand F; Pape HC; Pfeifer R
    Cytokine; 2018 Mar; 103():127-132. PubMed ID: 28969938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin.
    Wagner N; Jehl-Piétri C; Lopez P; Murdaca J; Giordano C; Schwartz C; Gounon P; Hatem SN; Grimaldi P; Wagner KD
    Cardiovasc Res; 2009 Jul; 83(1):61-71. PubMed ID: 19351742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity.
    Bonala S; Lokireddy S; Arigela H; Teng S; Wahli W; Sharma M; McFarlane C; Kambadur R
    J Biol Chem; 2012 Apr; 287(16):12935-51. PubMed ID: 22362769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.
    Ozawa C; Horiguchi M; Akita T; Oiso Y; Abe K; Motomura T; Yamashita C
    Biol Pharm Bull; 2016; 39(5):778-85. PubMed ID: 27150147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes.
    Zarei M; Barroso E; Palomer X; Escolà-Gil JC; Cedó L; Wahli W; Vázquez-Carrera M
    Clin Investig Arterioscler; 2019; 31(3):111-118. PubMed ID: 30987865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
    Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
    Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
    Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
    Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
    Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.
    Collino M; Benetti E; Miglio G; Castiglia S; Rosa AC; Aragno M; Thiemermann C; Fantozzi R
    Free Radic Biol Med; 2011 Jan; 50(2):345-53. PubMed ID: 21047550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
    Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
    Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
    Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.
    Phua WWT; Tan WR; Yip YS; Hew ID; Wee JWK; Cheng HS; Leow MKS; Wahli W; Tan NS
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
    Marin HE; Peraza MA; Billin AN; Willson TM; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM
    Cancer Res; 2006 Apr; 66(8):4394-401. PubMed ID: 16618765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.
    Yu S; Levi L; Casadesus G; Kunos G; Noy N
    J Biol Chem; 2014 May; 289(18):12748-58. PubMed ID: 24644281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.
    Adhikary T; Wortmann A; Schumann T; Finkernagel F; Lieber S; Roth K; Toth PM; Diederich WE; Nist A; Stiewe T; Kleinesudeik L; Reinartz S; Müller-Brüsselbach S; Müller R
    Nucleic Acids Res; 2015 May; 43(10):5033-51. PubMed ID: 25934804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.